0001104659-15-066590.txt : 20150923 0001104659-15-066590.hdr.sgml : 20150923 20150923060055 ACCESSION NUMBER: 0001104659-15-066590 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150918 FILED AS OF DATE: 20150923 DATE AS OF CHANGE: 20150923 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KYTHERA BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001436304 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 27200 WEST AGOURA ROAD STREET 2: SUITE 200 CITY: CALABASAS STATE: CA ZIP: 91301 BUSINESS PHONE: 818-587-4500 MAIL ADDRESS: STREET 1: 27200 WEST AGOURA ROAD STREET 2: SUITE 200 CITY: CALABASAS STATE: CA ZIP: 91301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smither John W CENTRAL INDEX KEY: 0001559583 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35663 FILM NUMBER: 151120287 MAIL ADDRESS: STREET 1: C/O KYTHERA BIOPHARMACEUTICALS, INC. STREET 2: 27200 WEST AGOURA ROAD, SUITE 200 CITY: CALABASAS STATE: CA ZIP: 91301 4 1 a4.xml 4 X0306 4 2015-09-18 0 0001436304 KYTHERA BIOPHARMACEUTICALS INC KYTH 0001559583 Smither John W C/O KYTHERA BIOPHARMACEUTICALS, INC. 30930 RUSSELL RANCH ROAD, 3RD FLOOR WESTLAKE VILLAGE CA 91362 0 1 0 0 Chief Financial Officer Common Stock 2015-09-18 4 M 0 1054 8.22 A 4422 D Common Stock 2015-09-18 4 S 0 1054 74.95 D 3368 D Common Stock 2015-09-22 4 M 0 3476 8.22 A 6844 D Common Stock 2015-09-22 4 S 0 3476 74.9 D 3368 D Common Stock 2015-09-22 4 M 0 2115 8.22 A 5483 D Common Stock 2015-09-22 4 S 0 2115 74.9 D 3368 D Common Stock 2015-06-26 5 G 0 E 1400 0 D 6216 I See footnote Stock Options 8.22 2015-09-18 4 M 0 1054 0 D 2022-02-01 Common Stock 1054 4328 D Stock Options 8.22 2015-09-22 4 M 0 3476 0 D 2022-02-01 Common Stock 3476 852 D Stock Options 8.22 2015-09-22 4 M 0 2115 0 D 2022-02-01 Common Stock 2115 13272 D Shares held by the 1994 Smither Family Trust dated March 1, 1994 as amended March 23, 2006. John W. Smither and Noretha V. Smither, Trustees (the "1994 Smither Family Trust"). 25% of the shares subject to the option vested on the first anniversary measured from January 1, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. The shares subject to these options vested 100% upon the achievement of certain performance milestones approved by the Issuer's Board of Directors. /s/ Keith Klein, as Attorney-in-Fact for John W. Smither 2015-09-22